Phase II Clinical Trial On Taxol As Single Agent In Locally Advanced And/Or Metastatic Or Recurrent Vulva Cancer Not Amenable For Surgery And/Or Radiotherapy.
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Paclitaxel (Primary)
- Indications Vulvovaginal cancer
- Focus Therapeutic Use
- 08 Dec 2015 Accrual to date is 6%, according to United Kingdom Clinical Research Network record.
- 31 May 2012 Additional lead trial investigators added as reported by United Kingdom Clinical Research Network record.
- 31 May 2012 New source identified and integrated (United Kingdom Clinical Research Network UKCRN927).